| abstract |
Provided are the aryl propionic acid derivative shown in formula (I), pharmaceutical composition, and method for preparation thereof and application thereof. The aryl propionic acid derivative described has good half-life, pharmacokinetic properties, and in vitro stability, can, when made into a formulation, achieve the functions of increasing effectiveness and reducing toxicity, and improves the defects of conventional non-steroidal anti-inflammatory drugs, such as frequent dosing, gastrointestinal side effects, and poor patient compliance. |